Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SIGLEC5 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | TSEN2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | ZNF234 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | PDE2A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | PUDP | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | AMPD2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | OTUD4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | AGPAT4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | AKAIN1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |